Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Immunovaccine and Oncothyreon to jointly develop cancer vaccine

July 1, 2010

EMA issues encouraging scientific advice on phase III perifosine trial in colorectal cancer

July 1, 2010

TXA-127 obtains FDA orphan drug status to enhance stem cell engraftment

July 1, 2010

TopoTarget presents novel Nampt inhibitors

July 1, 2010

Aeterna Zentaris and Almac to develop companion diagnostic for AEZS-108 cancer therapy

June 30, 2010

First-in-human data reported on anticancer agent PF-337210

June 30, 2010

Abbott identifies new kinase inhibitors

June 30, 2010

ArQule describes new RAF kinase inhibitors

June 30, 2010

Revlimid approved in Japan for relapsed or refractory multiple myeloma

June 29, 2010

TroVax to be evaluated in mesothelioma in phase I/II trial

June 29, 2010

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026